Fundraising Fox
Cisterna Biologics
YC S22San Diego, US · Founded 2022 · 2 employees · 1 known investors
Find your way into Cisterna Biologics
Sign up to see every warm intro you have to Cisterna Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Cisterna Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cisterna Biologics develops yeast-engineered mRNA manufacturing technology that can be selectively purified to drive protein expression in human cells. The company targets cost-effective, scalable, and non-immunogenic mRNA production for therapeutic applications.
Also known as Cisterna Biologic · Cisterna Biologics LLC · Cisterna Biologics LLC, Cisterna Biologic
AI & Machine LearningBiotechDeep TechHealthtechSynthetic BiologyTherapeuticsUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (S22)
Cisterna Biologics was founded in 2022 by Hari Bhaskaran.
Investors · 1
Related companies · 5
GamgeeGAMGEE develops personalised mRNA cancer vaccines for dogs, created from the animal's own tumour tissue to help its immune system fight the cancer. The company manages the full process end to end—from diagnosis and tissue sampling with the pet owner's vet, to genomic analysis and treatment delivery via veterinary oncologists—and is currently running clinical trials in Australia while accepting applications globally.
Helix NanotechnologiesHelixNano develops an mRNA platform aimed at applications including cancer treatment, COVID-19 vaccines, and environmental interventions. The company is working on a COVID-19 vaccine candidate for immunocompromised patients and other mRNA-based technologies.
Engage BioEngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
ParcelBioParcelBio develops APEXm, a proprietary mRNA platform that enhances protein expression for longer-lasting therapeutic effect compared to conventional mRNA technologies. The platform targets autoimmune disease, oncology, and therapeutic protein replacement applications.
Sensible BiotechnologiesSensible Biotechnologies develops a cell-based mRNA design and manufacturing platform that produces pure, low immunogenicity mRNA therapeutics for drug development. The platform addresses limitations of synthetic mRNA by enabling design-based biology approaches.
Companies working in the same space as Cisterna Biologics.
Legal entities · 1
corporate structureCisterna Biologics, Inc.
In the news
Frequently asked questions
- What does Cisterna Biologics do?
- Cisterna Biologics develops yeast-engineered mRNA manufacturing technology that can be selectively purified to drive protein expression in human cells. The company targets cost-effective, scalable, and non-immunogenic mRNA production for therapeutic applications.
- Who founded Cisterna Biologics?
- Cisterna Biologics was founded by Hari Bhaskaran in 2022.
- Who are Cisterna Biologics's investors?
- Cisterna Biologics's investors include Y Combinator.
- Where is Cisterna Biologics headquartered?
- Cisterna Biologics is headquartered in San Diego, US.